Scientific advisors
Prof. Francesco Bertoni
Prof. Francesco Bertoni obtained a Medical Degree magna cum laude (1994) and the Medical Oncology Specialty (1998) from the State University of Milan. Since 2019 he is Adjunct Professor at the Università della Svizzera italiana (USI). Since April 2003 Bertoni is the head of the Lymphoma Genomics group at IOR (IOSI Laboratory of Experimental Oncology until 2011). Since April 2007, he is the deputy director of the Institute. Bertoni actively participates to Swiss Cancer Research Group (SAKK), in which he is vice-president of the Project Group Lymphoma and member of the Project Group New Anticancer Treatment. Bertoni’s research topics are the development of new anti-lymphoma compounds and lymphoma genomics. He is the author or co-author of over 200 original papers, over 50 editorials or invited reviews, 20 book sections, one edited book, several abstracts at national and international meetings, and over ten patents.
Prof. Francesco Bertoni obtained a Medical Degree magna cum laude (1994) and the Medical Oncology Specialty (1998) from the State University of Milan. Since 2019 he is Adjunct Professor at the Università della Svizzera italiana (USI). Since April 2003 Bertoni is the head of the Lymphoma Genomics group at IOR (IOSI Laboratory of Experimental Oncology until 2011). Since April 2007, he is the deputy director of the Institute. Bertoni actively participates to Swiss Cancer Research Group (SAKK), in which he is vice-president of the Project Group Lymphoma and member of the Project Group New Anticancer Treatment. Bertoni’s research topics are the development of new anti-lymphoma compounds and lymphoma genomics. He is the author or co-author of over 200 original papers, over 50 editorials or invited reviews, 20 book sections, one edited book, several abstracts at national and international meetings, and over ten patents.
Dr. Behjatolah (BJ) Karbassi
Dr. Behjatolah M. Karbassi received his Ph.D. in Molecular Biology from Institute of Molecular genetics, Russian Academy of Sciences, Moscow, Russia in 1997. He did a postdoctoral training in tumor Immunology and vaccine development at the University of Pennsylvania, Philadelphia, PA, USA from 1998 to 2002. Dr. Karbassi is currently an Assistant Professor in the Department of Pathology at the University of Arkansas for Medical Sciences, Little Rock, AR, USA. He is also a member of Winthrop P. Rockefeller Cancer Institute. His major research interests include cancer immunotherapy and developing cancer therapeutics targeting glycan antigens. His research on development of peptide-based cancer vaccines is being evaluated in two on-going clinical trials in WPRCI. He has published more than 60 research articles in his field.
Dr. Behjatolah M. Karbassi received his Ph.D. in Molecular Biology from Institute of Molecular genetics, Russian Academy of Sciences, Moscow, Russia in 1997. He did a postdoctoral training in tumor Immunology and vaccine development at the University of Pennsylvania, Philadelphia, PA, USA from 1998 to 2002. Dr. Karbassi is currently an Assistant Professor in the Department of Pathology at the University of Arkansas for Medical Sciences, Little Rock, AR, USA. He is also a member of Winthrop P. Rockefeller Cancer Institute. His major research interests include cancer immunotherapy and developing cancer therapeutics targeting glycan antigens. His research on development of peptide-based cancer vaccines is being evaluated in two on-going clinical trials in WPRCI. He has published more than 60 research articles in his field.
Dr. Andreas G. Tzakos
Dr. Andreas G. Tzakos is Associate Professor of Organic Chemistry at the University of Ioannina, Greece. He is the head of a Chemical Biology Lab as also head of the Bioanalytical Center & Analytical Center that operate under the ISO:17025 accreditation. Andreas conducted his postdoctoral research as an EMBO fellow at the MRC Laboratory of Molecular Biology (Cambridge, UK) and received many prestigious grants and awards including Marie Curie, EMBO, FEBS, NATO, Leonidas Zervas, and his work on the discovery of potent bioactive compounds has been awarded by the Academy of Athens. His main research interest includes the design and development of cancer diagnostics, theranostics, tumor homing and tumor responsive drug delivery vehicles. He has authored more than 150 international publications in the field, one academic book, edited three books, participated in the development of 3 software, he is in the editorial board of several International Journals and has five patents.
Dr. Andreas G. Tzakos is Associate Professor of Organic Chemistry at the University of Ioannina, Greece. He is the head of a Chemical Biology Lab as also head of the Bioanalytical Center & Analytical Center that operate under the ISO:17025 accreditation. Andreas conducted his postdoctoral research as an EMBO fellow at the MRC Laboratory of Molecular Biology (Cambridge, UK) and received many prestigious grants and awards including Marie Curie, EMBO, FEBS, NATO, Leonidas Zervas, and his work on the discovery of potent bioactive compounds has been awarded by the Academy of Athens. His main research interest includes the design and development of cancer diagnostics, theranostics, tumor homing and tumor responsive drug delivery vehicles. He has authored more than 150 international publications in the field, one academic book, edited three books, participated in the development of 3 software, he is in the editorial board of several International Journals and has five patents.